After having had the privilege to serve the medtech community
for over 12 years, the Health Technology Exchange (HTX)
will be closed for business, effective September 30, 2016.

In line with the consolidation mandate directed by HTX’s funding ministries, our active programs have been transitioned to a number of partner organizations in Ontario:

  • The REACH Innovation Procurement Program that was designed to help Ontario healthcare providers use new ways to evaluate, procure and more rapidly adopt innovative medical technologies, addressing high-priority health system needs in Ontario, has been transitioned to the Ontario Centres of Excellence (OCE) (
  • The Health Technology Commercialization Program (HTCP) investment portfolio will be transitioned over to and managed by the Investment Accelerator Fund (IAF) at MaRS. (
  • Discussions are underway with local agencies regarding the effective transition of the Harmony Project, the Soft Landing Program and the Medtech RISE database. Our goal is to ensure that these valuable resources are effectively transitioned in order to provide maximal access and impact to the Ontario medtech ecosystem.

The outstanding success of HTX over the years would not have been possible without the contributions of many:

  • Our extremely dedicated and experienced colleagues and staff at HTX;
  • Our Board and various Advisory Committees;
  • Our provincial, national and international partners and colleagues that work diligently at moving the innovation agenda forward;
  • Our funders at the the Ontario Ministry of Research and Innovation, Ontario Ministry of Government and Consumer Services, Ontario Centres of Excellence (OCE), Industrial Research Assistance Program (IRAP), and Canadian Institutes of Health Research (CIHR); and most importantly
  • Our investee and collaborator companies.

HTX was founded in 2004 with a focus on breaking down the silos dividing providers, innovators, financiers, regulators, and payers within Ontario’s medtech ecosystem. Over the years, HTX developed deep experience in medtech company creation, financing, evidence generation, market access and adoption issues facing medtech companies. Our niche focus allowed us to interact with numerous innovative startups, both locally and nationally, providing maximal opportunities for connectivity, knowledge translation, accelerated commercialization and access to capital. And look how far the Ontario medtech ecosystem has come: the awareness around medtech commercialization, processes, supports and funding we now have in place would have seemed unimaginable in the medtech climate at our inception.




We are excited for the opportunities that the next phase of Ontario’s innovation journey will bring
for our community and encourage you to continue building on our collective success.

Thank you for giving us the opportunity to serve you.